Search results for "I-cell disease"

showing 3 items of 3 documents

Characterization of T–cell subclasses and NK–cells in lysosomal disorders by immuno–electron microscopy

1994

Previous studies have shown that B and T lymphocytes are affected in lysosomal disorders. The aim of this study was to investigate the involvement of subclasses of T lymphocytes and natural killer cells in lysosomal diseases. CD4+, CD8+, and CD56+ cells were immunomagnetically separated from peripheral blood mononuclear cells in 10 patients with various lysosomal diseases--including one patient each with infantile, late infantile, and juvenile neuronal ceroid-lipfuscinoses, two patients with mucopolysaccharidosis (MPS) type I and four patients with MPS type III, and one patient with mucolipidosis type II; all lymphocytes were studied by light and electron microscopy. Respective vacuolar or …

CD4-Positive T-LymphocytesPathologymedicine.medical_specialtyHistologyT-LymphocytesMucopolysaccharidosisT cellImmunoblottingCD8-Positive T-LymphocytesBiologyPathology and Forensic MedicineNatural killer cellPhysiology (medical)Lysosomal storage diseasemedicineHumansMicroscopy ImmunoelectronT lymphocyteMucopolysaccharidosesmedicine.diseaseKiller Cells Naturalmedicine.anatomical_structureNeurologyNeuronal ceroid lipofuscinosisNeurology (clinical)I-cell diseaseLysosomesCD8Neuropathology and Applied Neurobiology
researchProduct

Oligosaccharide and Ganglioside Neuraminidase Activities of Mucolipidosis I (Sialidosis) and Mucolipidosis II (I-Cell Disease) Fibroblasts

1979

Fibroblasts cultured from the skin of patients with the genetic diseases mucolipidosis I and mucolipidosis II were found deficient in a neuraminidase specific for both an α23 and and α2 6 type of neuraminosyl linkage of sialyl oligosaccharides. Obligate heterozygotes (parents) showed an intermediate activity in mucolipidosis I, but a normal one in mucolipidosis II. The neuraminidase activity of mucolipidosis I fibroblasts towards gangliosides, measured at pH 4.5 in the presence of Triton X-100, was within the range of normal controls with gangliosides Gm3 and GD3, but somewhat diminished with a bovine brain ganglioside preparation. In mucolipidosis II, neuraminidase activity was markedly de…

NeuraminidaseOligosaccharidesBiochemistryCell LinePolyethylene GlycolsSubstrate SpecificityMucolipidosesGangliosidesmedicineHumansGanglioside GD3SialidosisCells CulturedSkinchemistry.chemical_classificationGangliosidebiologyMucolipidosisGenetic Carrier ScreeningHeterozygote advantageFibroblastsOligosaccharidemedicine.diseaseKineticschemistryBiochemistrybiology.proteinlipids (amino acids peptides and proteins)I-cell diseaseNeuraminidaseEuropean Journal of Biochemistry
researchProduct

Prenatal diagnosis of mucolipidosis II (I-cell disease)

1976

A pregnancy at risk for mucolipidosis II (I-cell disease) was monitored in which an affected fetus was predicted on the basis of the analyses of lysosomal hydrolases in amniotic fluid and cultured amniotic fluid cells, and by the demonstration of an excessive accumulation of [35S] sulfate-labeled glycosaminoglycans in cultured amniotic cells. This diagnosis was confirmed by performing enzyme assays and [35S] sulfate incorporation studies on material derived from the aborted fetus.

medicine.medical_specialtyAmniotic fluidHydrolasesPrenatal diagnosisSulfur RadioisotopesAndrologyGlycosaminoglycanPregnancyPrenatal DiagnosisInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingCells CulturedGlycosaminoglycansPregnancyFetusbusiness.industryMucolipidosisAborted FetusGeneral MedicineMucopolysaccharidosesAmniotic Fluidmedicine.diseaseEndocrinologyPediatrics Perinatology and Child HealthFemaleI-cell diseaseLysosomesbusinessEuropean Journal of Pediatrics
researchProduct